Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease

Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load

(2019) Sung-Hee Han et al.   PLoS One

Multidrug resistant Clostridium difficile ribotype 027 in southwestern Virginia, 2007 to 2013

(2018) R.J. Carman et al.   ANAEROBE

Potential of real-time PCR threshold cycle (C T ) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer

(2018) Mini Kamboj et al.   JOURNAL OF INFECTION

Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)?

(2017) C. E. Berry et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

(2017) Ferric C. Fang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

DADA2: High-resolution sample inference from Illumina amplicon data

(2016) Benjamin J Callahan et al.   NATURE METHODS

Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study

(2016) Christian Milani et al.   Scientific Reports

Overdiagnosis ofClostridium difficileInfection in the Molecular Test Era

(2015) Christopher R. Polage et al.   JAMA Internal Medicine

Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates

(2014) Hoonmo L. Koo et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform

(2013) James J. Kozich et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection

(2013) J. H. Boone et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Impact of Change to Molecular Testing for Clostridium difficile Infection on Healthcare Facility–Associated Incidence Rates

(2013) Rebekah W. Moehring et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data

(2013) Paul J. McMurdie et al.   PLoS One

Outcomes in patients tested for Clostridium difficile toxins

(2012) Christopher R. Polage et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clostridium difficile binary toxin (CDT) and diarrhea

(2011) Robert J. Carman et al.   ANAEROBE

Rapid Molecular Characterization of Clostridium difficile and Assessment of Populations of C. difficile in Stool Specimens

(2009) D. Wroblewski et al.   JOURNAL OF CLINICAL MICROBIOLOGY